Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07039396 · ClinicalTrials.gov registry record · NA
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers
A NA study of Diabetic Foot Ulcer, sponsored by NuScience Medical Biologics.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 3
- Study locations
NCT07039396: Recruiting NA study of Diabetic Foot Ulcer, sponsored by NuScience Medical Biologics.
NCT07039396 is a NA study of Diabetic Foot Ulcer that is actively recruiting participants, run by NuScience Medical Biologics. The registered enrollment target is 10 participants, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07039396, a NA study of Diabetic Foot Ulcer, is actively recruiting participants, sponsored by NuScience Medical Biologics.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Diabetic Foot Ulcers
Primary Outcome
The primary endpoint will be the percentage of target ulcers that achieve complete wound closure by manual measurement utilizing a ruler.
Conditions Studied
Interventions
- OTHER NeoThelium FT (HCT/P 361)
Study Locations (3)
Louisiana
- MedCentris of Alexandria - Alexandria
- MedCentris of Leesville - Leesville
- MedCentris of Many - Many
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-08-26 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT07039396 shows while recruiting
NCT07039396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which NeoThelium FT (HCT/P 361) is the first listed.
NCT07039396 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT07039396 about?
NCT07039396 is a clinical study titled "Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers". This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Diabetic Foot Ulcers
What is the current status of trial NCT07039396?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-08-26. Estimated completion is 2026-06-01.
What conditions does trial NCT07039396 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT07039396?
The interventions under investigation include: NeoThelium FT (HCT/P 361) (OTHER).
Who is sponsoring clinical trial NCT07039396?
This trial is sponsored by NuScience Medical Biologics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07039396 being conducted?
This trial has 3 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07039396's enrollment target sits among peer trials
10 67th of 67 the lowest of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI